AstraZeneca | AZN - Cost Of Sales

Stock Price
15,276.00
Daily Change
60.00 0.39%
Monthly
4.24%
Yearly
52.49%
Q2 Forecast
14,983.64

AstraZeneca reported $3.27B in Cost of Sales for its fiscal quarter ending in December of 2025.





Cost Of Sales Change Date
AbbVie USD 4.55B 757M Dec/2025
Alcon AG USD 1.2B 46M Dec/2025
Almirall EUR 191.5M 2.29M Dec/2025
Amgen USD 1.79B 128M Dec/2025
argenx SE USD 149.69M 40.26M Dec/2025
AstraZeneca USD 3.27B 471M Dec/2025
Autolus Therapeutics Ltd USD 25.33M 3.31M Dec/2025
Bayer EUR 4.5B 194M Dec/2025
Biogen USD 810.1M 205.1M Sep/2025
Bristol-Myers Squibb USD 4.92B 657M Dec/2025
Eli Lilly USD 3.37B 363.7M Dec/2025
Fresenius EUR 4.45B 262M Dec/2025
Fresenius Medical Care EUR 3.68B 38.37M Dec/2025
Galapagos EUR 455K 84.28M Dec/2025
Genmab DKK 81M 23M Dec/2025
Gilead Sciences USD 1.62B 50M Dec/2025
GlaxoSmithKline GBP 2.61B 377M Dec/2025
GRIFOLS EUR 1.29B 163.12M Dec/2025
Haleon GBP 972.5M 258.5M Jun/2025
Hikma Pharmaceutical USD 959M 492.5M Dec/2025
Lonza CHF 2.28B 189M Jun/2025
Merck EUR 2.29B 183M Dec/2025
Merck USD 3.32B 531M Dec/2025
Novartis USD 3.54B 3M Dec/2025
Orion EUR 186.6M 17.6M Dec/2025
Pfizer USD 6.29B 2.12B Dec/2025
Philips EUR 2.81B 417M Dec/2025
Recordati EUR 199.91M 20.12M Sep/2025
Regeneron Pharmaceuticals USD 584.6M 63M Dec/2025
Roche Holding CHF 8.48B 4.61B Dec/2025
Sanofi EUR 4.29B 421M Dec/2025
UCB EUR 1.07B 146M Dec/2025